Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:31 AM UTC
| NCT Number | NCT05727904 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 670 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT05727904 is currently recruiting participants. This phase3 study for melanoma is actively seeking new participants at 24 locations across the United States. The study is sponsored by Iovance Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05727904 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05727904 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.